ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.009,06
0,58%
S&P 500
5.129,33
1,29%
Dow Jones
38.731,88
1,32%
Euro vs US Dollar
1,07736
0,41%
Bitcoin
61.644,58
4,27%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. SurModics Inc (SRDX)

  7. SurModics Inc (SRDX) News

SRDX SurModics Inc

34,95
0,40 (1,16%)
Zuletzt aktualisiert: 15:35:43
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
SurModics Inc SRDX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,40 1,16% 34,95 15:35:43
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
35,21 34,95 35,21 34,55
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00BWSurmodics Reports Second Quarter of Fiscal Year 2024..
19.4.202413:00BWSurmodics to Report Second Quarter of Fiscal 2024 Financial..
27.2.202414:00BWSurmodics to Participate in Upcoming Investor Conferences in..
12.2.202422:22EDGAR2Form 8-K - Current report
12.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202417:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202415:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.2.202413:00EDGAR2Form 8-K - Current report
01.2.202413:00BWSurmodics Reports First Quarter of Fiscal Year 2024..
29.1.202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23.1.202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202413:30BWSurmodics Announces Successful Early Clinical Use of Pounce™..
16.1.202413:30BWSurmodics to Host Virtual Annual Meeting of Shareholders
03.1.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
18.12.202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06.12.202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202316:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17.11.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202313:30BWSurmodics Announces TRANSCEND Trial 36-Month Data Presented..
14.11.202322:05BWSurmodics to Participate in the Piper Sandler Healthcare..
08.11.202313:30BWSurmodics Reports Fourth Quarter and Fiscal Year 2023..
08.11.202313:00EDGAR2Form 8-K - Current report
07.11.202313:30BWSurmodics Announces SWING Trial 24-Month Data to be..
31.10.202312:30BWSurmodics Announces Launch of Preside™ Medical Device..
10.10.202313:30BWSurmodics to Report Fourth Quarter and Fiscal 2023 Financial..
03.10.202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202323:05BWSurmodics to Participate in Upcoming Investor Conferences in..
02.8.202314:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202313:31BWSurmodics Reports Third Quarter of Fiscal Year 2023..

Kürzlich von Ihnen besucht

NASDAQ
SRDX
SurModics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten